| Literature DB >> 29870883 |
Rafał Moszczyński-Pętkowski1, Jakub Majer2, Małgorzata Borkowska2, Łukasz Bojarski3, Sylwia Janowska3, Mikołaj Matłoka3, Filip Stefaniak2, Damian Smuga2, Katarzyna Bazydło3, Krzysztof Dubiel2, Maciej Wieczorek3.
Abstract
New compounds containing [1,2,4]triazolo [1,5-a]pyridine (I), pyrazolo [1,5-a]pyridine (II), 1H-1,3-benzodiazole (III) and imidazo [1,2-a]pyrimidine (IV) backbones were designed and synthesized for PDE10A interaction. Among these compounds, 1H-1,3-benzodiazoles and imidazo [1,2-a]pyrimidines showed the highest affinity for PDE10A enzyme as well as good metabolic stability. Both classes of compounds were identified as selective and potent PDE10A enzyme inhibitors.Entities:
Keywords: 1H-1,3-benzodiazoles; Imidazo[1,2-a]pyrimidines; PDE10A
Mesh:
Substances:
Year: 2018 PMID: 29870883 DOI: 10.1016/j.ejmech.2018.05.043
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514